← Back to Clinical Trials
Recruiting NCT05528484

NCT05528484 Self-reported Outcomes of Patients in ERAS Nursing

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05528484
Status Recruiting
Phase
Sponsor The Second Hospital of Shandong University
Condition Enhanced Recovery After Surgery
Study Type INTERVENTIONAL
Enrollment 600 participants
Start Date 2019-10-01
Primary Completion 2023-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
ERAS nursingnon eras nursing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 600 participants in total. It began in 2019-10-01 with a primary completion date of 2023-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

We aimed to evaluate the effect of ERAS nursing program on self-reported outcomes of patients undergoing minimally invasive lung cancer surgery, and compared the differences in length of hospital stay, complications, and readmission rate between ERAS and non-ERAS nursing programs

Eligibility Criteria

Inclusion Criteria: * ≥18years,Minimally invasive elective surgery,cooperate Exclusion Criteria: * Pneumonectomy was performed and converted to open surgery Surgery intensive care, unable to cooperate (language Speech disorders, psychopathology)

Contact & Investigator

Central Contact

ying liu

✉ liuxia5945@126.com

📞 17660081909

Frequently Asked Questions

Who can join the NCT05528484 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Enhanced Recovery After Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05528484 currently recruiting?

Yes, NCT05528484 is actively recruiting participants. Contact the research team at liuxia5945@126.com for enrollment information.

Where is the NCT05528484 trial being conducted?

This trial is being conducted at Jinan, China.

Who is sponsoring the NCT05528484 clinical trial?

NCT05528484 is sponsored by The Second Hospital of Shandong University. The trial plans to enroll 600 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology